CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5454-5464

  Prechtel, Alexander T ^a   Turza, Nadine M ^a   Theodoridis, Alexandros A ^a   Steinkasserer, Alexander ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN; MESSENGER RNA; SMALL INTERFERING RNA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ELECTROPORATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 34247636157     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5454     Document Type: Article

References (60)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Dustin, M. L., and J. A. Cooper. 2000. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1: 23-29.
3. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
4. Dilioglou, S., J. M. Cruse, and R. E. Lewis. 2003. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp. Mol. Pathol. 75: 217-227.
5. Pardoll, D. M. 2002. Spinning molecular immunology into successful immunotherapy. Nat Rev. Immunol. 2: 227-238.
6. Cao, W., S. H. Lee, and J. Lu. 2005. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem. J. 385: 85-93.
7. Wolenski, M., S. O. Cramer, S. Ehrlich, C. Steeg, B. Fleischer, and A. von Bonin. 2003. Enhanced activation of CD83-positive T cells. Scand. J. Immunol. 58: 306-311.
8. Zhou, L. J., R. Schwarting, H. M. Smith, and T. F. Tedder. 1992. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149: 735-742.
9. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821-3835.
10. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588-2592.
11. Hock, B. D., M. Kato, J. L. McKenzie, and D. N. J. Hart. 2001. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol. 13: 959-967.
12. Hock, B. D., L. F. Haring, A. Steinkasserer, K. G. Taylor, W. N. Patton, and J. L. McKenzie. 2004. The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leuk. Res. 28: 237-241.
13. Salio, M., M. Cella, M. Suter, and A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29: 3245-3253.
14. Kruse, M., O. Rosorius, F. Kratzer, G. Stelz, C. Kuhnt, G. Schuler, J. Hauber, and A. Steinkasserer. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74: 7127-7136.
15. Senechal, B., A. M. Boruchov, J. L. Reagan, D. N. Hart, and J. W. Young. 2004. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103: 4207-4215.
16. Lechmann, M., D. J. Krooshoop, D. Dudziak, E. Kremmer, C. Kuhnt, C. G. Figdor, G. Schuler, and A. Steinkasserer. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194: 1813-1821.
17. Scholler, N., M. Hayden-Ledbetter, A. Dahlin, I. Hellstrom, K. E. Hellstrom, and J. A. Ledbetter. 2002. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 168: 2599-2602.
18. Kruse, M., O. Rosorius, F. Kratzer, D. Bevec, C. Kuhnt, A. Steinkasserer, G. Schuler, and J. Hauber. 2000. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med. 191: 1581-1590.
19. Bevec, D., and J. Hauber. 1997. Eukaryotic initiation factor 5A activity and HIV-1 Rev function. Biol. Signals 6: 124-133.
20. Park, M. H., E. C. Wolff, and J. E. Folk. 1993. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 4: 95-104.
21. Zinser, E., M. Lechmann, A. Golka, M. B. Lutz, and A. Steinkasserer. 2004. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200: 345-351.
22. Dudziak, D., F. Nimmerjahn, G. W. Bornkamm, and G. Laux. 2005. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J. Immunol. 174: 6672-6676.
23. Hock, B. D., J. L. O'Donnell, K. Taylor, A. Steinkasserer, J. L. McKenzie, A. G. Rothwell, and K. L. Summers. 2006. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients. Tissue Antigens 67: 57-60.
24. + T cells. J. Immunol. 166: 3865-3872.
25. Yang, S., Y. Yang, J. Raycraft, H. Zhang, S. Kanan, Y. Guo, Z. Ronai, I. Hellstrom, and K. E. Hellstrom. 2004. Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137. Proc. Natl. Acad. Sci. USA 101: 4990-4995.
26. + T cell development in the thymus. Cell 108: 755-767.
27. Tuschl, T., and A. Borkhardt. 2002. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol. Interv. 2: 158-167.
28. Tuschl, T. 2001. RNA interference and small interfering RNAs. Chembiochem 2: 239-245.
29. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
30. Elbashir, S. M., W. Lendeckel, and T. Tuschl. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15: 188-200.
31. Prechtel, A. T., N. M. Turza, A. A. Theodoridis, M. Kummer, and A. Steinkasserer. 2006. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation. J. Immunol. Methods 311: 139-152.
32. Liu, G., H. Ng, Y. Akasaki, X. Yuan, M. Ehtesham, D. Yin, K. L. Black, and J. S. Yu. 2004. Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur. J. Immunol. 34: 1680-1687.
33. Hill, J. A., T. E. Ichim, K. P. Kusznieruk, M. Li, X. Huang, X. Yan, R. Zhong, E. Cairns, D. A. Bell, and W. P. Min. 2003. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J. Immunol. 171: 691-696.
34. Lossos, J. S., D. K. Czerwinski, M. A. Wechser, and R. Levy. 2003. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17: 789-795.
35. Lechmann, M., E. Kremmer, H. Sticht, and A. Steinkasserer. 2002. Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies. Protein Expression Purif. 24: 445-452.
36. McManus, M. T., B. B. Haines, C. P. Dillon, C. E. Whitehurst, P. L. van, J. Chen, and P. A. Sharp. 2002. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169: 5754-5760.
37. Obrig, T. G., W. J. Culp, W. L. McKeehan, and B. Hardesty. 1971. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 246: 174-181.
38. Gu, X., J. Xiang, Y. Yao, and Z. Chen. 2006. Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells. Scand. J. Immunol. 64: 588-594.
39. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
40. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1: 311-316.
41. Ebner, S., G. Ratzinger, B. Krosbacher, M. Schmuth, A. Weiss, D. Reider, R. A. Kroczek, M. Herold, C. Heufler, P. Fritsch, and N. Romani. 2001. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 166: 633-641.
42. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
43. Zinser, E., N. Turza, and A. Steinkasserer. 2004. CNI-1493 mediated suppression of dendritic cell activation in vitro and in vivo. Immunobiology 209: 89-97.
44. Hauber, I., D. Bevec, J. Heukeshoven, F. Kratzer, F. Horn, A. Choidas, T. Harrer, and J. Hauber. 2005. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J. Clin. Invest. 115: 76-85.
45. Prechtel, A. T., N. M. Turza, D. J. Kobelt, J. I. Eisemann, R. S. Coffin, Y. McGrath, C. Hacker, X. Ju, M. Zenke, and A. Steinkasserer. 2005. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 86: 1645-1657.
46. Bantounas, I., L. A. Phylactou, and J. B. Uney. 2004. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol. 33: 545-557.
47. Hannon, G. J. 2002. RNA interference. Nature 418: 244-251.
48. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829.
49. Hornung, V., M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, et al. 2005. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11: 263-270.
50. Sioud, M. 2005. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348: 1079-1090.
51. Schlee, M., V. Hornung, and G. Hartmann. 2006. siRNA and isRNA: two edges of one sword. Mol. Ther. 14: 463-470.
52. Cullen, B. R. 2006. Enhancing and confirming the specificity of RNAi experiments. Nat. Methods 3: 677-681.
53. Pei, Y., and T. Tuschl. 2006. On the art of identifying effective and specific siRNAs. Nat. Methods 3: 670-676.
54. Klein, E., S. Koch, B. Borm, J. Neumann, V. Herzog, N. Koch, and T. Bieber. 2005. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int. Immunol. 17: 477-487.
55. + T cells and preferential enrichment for antigen specificity. Blood 107: 1528-1536.
56. + T cells. J. Immunol. 173: 2995-3001.
57. Saito, T., and T. Yokosuka. 2006. Immunological synapse and microclusters: the site for recognition and activation of T cells. Curr. Opin. Immunol. 18: 305-313.
58. Davis, D. M., and M. L. Dustin. 2004. What is the importance of the immunological synapse? Trends Immunol. 25: 323-327.
59. Lanzavecchia, A., and F. Sallusto. 2001. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat. Immunol. 2: 487-492.
60. Sallusto, F., and A. Lanzavecchia. 2002. The instructive role of dendritic cells on T-cell responses. Arthritis Res. 4: S127-S132.